Valiloxybate

N/A

Report date: 2026/02/04 12:00:40
NME

Base Information

Drug NameValiloxybate
Drug Alias NameXW-10172XWL-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor agonists
TargetsGamma-Aminobutyric Acid B Receptor
Therapy Area/IndicationsDisorders of Excessive SomnolenceParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesXw Laboratories Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDisorders of Excessive SomnolenceParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A